Vascular News and Research

RSS

Neuren reports successful NNZ-2566 safety trial results

Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).

16 Jan 2007

Milk eliminates cardiovascular health benefits of tea

Research published on-line in European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.

9 Jan 2007

Milk wipes out heart benefits offered by tea

Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.

9 Jan 2007

Medicare begins to cover ultrasounds to detect aortic aneurysms

Medicare on Jan. 1 began to cover ultrasounds to detect abdominal aortic aneurysms in beneficiaries at high risk for the condition, the Charlotte Observer reports.

7 Jan 2007

High uric acid levels indicate risk for cognitive problems in old age

Researchers at the Johns Hopkins and Yale university medical schools have found that a simple blood test to measure uric acid, a measure of kidney function, might reveal a risk factor for cognitive problems in old age.

2 Jan 2007

Vascular targeted nanoparticles for imaging and treatment of brain tumors

Combining two promising approaches to diagnosing and treating cancer, a multidisciplinary research team at the University of Michigan has created a targeted multifunctional polymer nanoparticle that successfully images and kills brain tumors in laboratory animals.

4 Dec 2006

Poor memory and slow reactions linked to heart attacks

According to British research, people with a below average mental agility are prone to heart attacks.

27 Nov 2006

VNUS Medical Technologies announces favorable ruling in patent case

VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").

23 Nov 2006

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.

8 Nov 2006

Doctors warned that commonly used painkillers linked to increased risk of heart attacks

Doctors in the UK are being warned that commonly used painkillers such as ibuprofen can increase the risk of heart attacks if taken over long periods.

25 Oct 2006

New study to evaluate whether nutrient-based factors slow the progression of age-related macular degeneration

UT Southwestern Medical Center is participating in a nationwide study investigating whether modified combinations of vitamins, minerals and fish oil products can slow the progression of vision loss from age-related macular degeneration.

24 Oct 2006

New drug gives hope to lung cancer victims

More people die from lung cancer than any other type of cancer and the prognosis for the disease is poor.

28 Sep 2006

Carbon monoxide shown to reverse symptoms of pulmonary hypertension

In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.

20 Sep 2006

New campaign to educate about peripheral arterial disease

More than 8 million men and women - one in 20 adults - have peripheral arterial disease (P.A.D), a largely unrecognized condition which puts them at risk for heart attack and stroke.

13 Sep 2006

New class of super NSAIDs

Building on previous work, researchers at the University of Pennsylvania School of Medicine have found that deleting an inflammation enzyme in a mouse model of heart disease slowed the development of atherosclerosis.

12 Sep 2006

When inequality pays dividends

When there are limited treatments for serious diseases, such as bird flu and HIV-AIDS, city residents should be first in line for the drugs ahead of those in rural areas to most effectively contain the risk to the community, according to research led by a University of New South Wales (UNSW) academic.

12 Sep 2006

Drug can quickly mobilize angiogenic cells to repair injury

To speed healing at sites of injury - such as heart muscle after a heart attack or brain tissue after a stroke - doctors would like to be able to hasten the formation of new blood vessels.

7 Sep 2006

Ageism is endemic in health services

In England, decades of health service underfunding have provided an environment in which ageism has flourished, writes Professor John Young in an editorial.

7 Sep 2006

Targeted nanoparticles to improve Boron-Neutron capture therapy

Boron-neutron capture therapy (BNCT) is an experimental treatment for virulent brain cancer that aims to kill malignant cells by generating high-energy alpha particles inside tumors.

5 Sep 2006

Endovascular repair of thoracic and abdominal aortic diseases as an alternative to open surgery in patients at high surgical risk

World Congress of Cardiology Report - Acute aortic syndromes, such as large thoracic and abdominal aortic aneurysms with impending rupture, complicated acute type B dissections, traumatic rupture of thoracic aorta, still represent life-threatening conditions.

5 Sep 2006